Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « Keywords » - entrée « Candida albicans (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Candida albicans (cytology) < Candida albicans (drug effects) < Candida albicans (enzymology)  Facettes :

List of bibliographic references indexed by Candida albicans (drug effects)

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000190 (2019) Yu-Wen Chen [Taïwan] ; Ying-Chieh Yeh [Taïwan] ; Hsueh-Fen Chen [Taïwan] ; Ruei-Ching Chen [Taïwan] ; Guan-Yu Lin [Taïwan] ; Yu-Ting Chen [Taïwan] ; Chung-Yu Lan [Taïwan]The small GTPase Rhb1 is involved in the cell response to fluconazole in Candida albicans.
000448 (2018) Faiza Asghar [République populaire de Chine] ; Hongbo Yan [République populaire de Chine] ; Linghuo Jiang [République populaire de Chine]The putative transcription factor CaMaf1 controls the sensitivity to lithium and rapamycin and represses RNA polymerase III transcription in Candida albicans.
000601 (2018) Linghuo Jiang [République populaire de Chine] ; Hongbo Pan [République populaire de Chine]Functions of CaPhm7 in the regulation of ion homeostasis, drug tolerance, filamentation and virulence in Candida albicans.
000651 (2018) Nitesh Kumar Khandelwal [Inde] ; Neeraj Chauhan [États-Unis] ; Parijat Sarkar [Inde] ; Brooke D. Esquivel [États-Unis] ; Paola Coccetti [Italie] ; Ashutosh Singh [Inde] ; Alix T. Coste [Suisse] ; Meghna Gupta [Inde, États-Unis] ; Dominique Sanglard [Suisse] ; Theodore C. White [États-Unis] ; Murielle Chauvel [France] ; Christophe D'Enfert [France] ; Amitabha Chattopadhyay [Inde] ; Naseem A. Gaur ; Alok Kumar Mondal [Inde] ; Rajendra Prasad [Oman, Inde]Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling.
000774 (2017) Ning-Ning Liu [États-Unis] ; Peter R. Flanagan [Irlande (pays)] ; Jumei Zeng [États-Unis] ; Niketa M. Jani [États-Unis] ; Maria E. Cardenas [États-Unis] ; Gary P. Moran [Irlande (pays)] ; Julia R. Köhler [États-Unis]Phosphate is the third nutrient monitored by TOR in Candida albicans and provides a target for fungal-specific indirect TOR inhibition.
000B35 (2016) Jinrong Feng [République populaire de Chine] ; Yinong Duan [République populaire de Chine] ; Wei Sun [République populaire de Chine] ; Yongwei Qin [République populaire de Chine] ; Zhong Zhuang [République populaire de Chine] ; Dandan Zhu [République populaire de Chine] ; Xiaolei Sun [République populaire de Chine] ; Linghuo Jiang [Oman]CaTip41 regulates protein phosphatase 2A activity, CaRad53 deactivation and the recovery of DNA damage-induced filamentation to yeast form in Candida albicans.
000B60 (2016) Rasmus Bojsen [Danemark] ; Birgitte Regenberg [Danemark] ; David Gresham [États-Unis] ; Anders Folkesson [Danemark]A common mechanism involving the TORC1 pathway can lead to amphotericin B-persistence in biofilm and planktonic Saccharomyces cerevisiae populations.
000C90 (2015) Ana Gil-Bona [Espagne] ; Lucía Monteoliva [Espagne] ; Concha Gil [Espagne]Global Proteomic Profiling of the Secretome of Candida albicans ecm33 Cell Wall Mutant Reveals the Involvement of Ecm33 in Sap2 Secretion.
001047 (2013) Jinrong Feng [République populaire de Chine] ; Yunying Zhao ; Yinong Duan ; Linghuo JiangGenetic interactions between protein phosphatases CaPtc2p and CaPph3p in response to genotoxins and rapamycin in Candida albicans.
001234 (2011) Sharon C-A Chen [Australie] ; Russell E. Lewis ; Dimitrios P. KontoyiannisDirect effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.
001265 (2011) Catrin Stichternoth [Allemagne] ; Alida Fraund ; Eleonora Setiadi ; Luc Giasson ; Anna Vecchiarelli ; Joachim F. ErnstSch9 kinase integrates hypoxia and CO2 sensing to suppress hyphal morphogenesis in Candida albicans.
001287 (2011) Julie Shareck [Canada] ; Pierre BelhumeurModulation of morphogenesis in Candida albicans by various small molecules.
001384 (2010) Xichuan Li [République populaire de Chine] ; Wei Du ; Jingwen Zhao ; Lilin Zhang ; Zhiyan Zhu ; Linghuo JiangThe MAP kinase-activated protein kinase Rck2p regulates cellular responses to cell wall stresses, filamentation and virulence in the human fungal pathogen Candida albicans.
001443 (2010) Joanne M. Kingsbury [États-Unis] ; John H. Mccusker [États-Unis]Cytocidal amino acid starvation of Saccharomyces cerevisiae and Candida albicans acetolactate synthase (ilv2{Delta}) mutants is influenced by the carbon source and rapamycin.
001579 (2008) Xichuan Li [République populaire de Chine] ; Xueqin Huang ; Jingwen Zhao ; Jing Zhao ; Yirui Wei ; Linghuo JiangThe MAP kinase-activated protein kinase Rck2p plays a role in rapamycin sensitivity in Saccharomyces cerevisiae and Candida albicans.
001617 (2008) Layla F. Martins [Brésil] ; Monica Montero-Lomelí ; Claudio A. Masuda ; Fabio S A. Fortes ; Jose O. Previato ; Lucia Mendonça-PreviatoLithium-mediated suppression of morphogenesis and growth in Candida albicans.
001647 (2008) Ronak Vakil [États-Unis] ; Kayla Knilans ; David Andes ; Glen S. KwonCombination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.
001814 (2005) G E Palmer [États-Unis] ; M N Kelly ; J E SturtevantThe Candida albicans vacuole is required for differentiation and efficient macrophage killing.
001A06 (2001) M C Cruz [États-Unis] ; A L Goldstein ; J. Blankenship ; M. Del Poeta ; J R Perfect ; J H Mccusker ; Y L Bennani ; M E Cardenas ; J. HeitmanRapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
001A37 (2000) A. Fang [États-Unis] ; G K Wong ; A L DemainEnhancement of the antifungal activity of rapamycin by the coproduced elaiophylin and nigericin.
001A77 (1998) G K Wong [États-Unis] ; S. Griffith ; I. Kojima ; A L DemainAntifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Candida albicans (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Candida albicans (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Candida albicans (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020